StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca total assets

Total assets on the balance sheet at the end of each period.

AstraZeneca's total assets was $115.83B at Jun 30, 2026. For fiscal 2025 it was $114.07B, up 9.6% from the year before. Over ten years it grew 6.6% a year on average. The highest annual figure on record is $114.07B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$114.07B+9.6%
FY2024Dec 31, 2024$104.04B+2.9%
FY2023Dec 31, 2023$101.12B+4.8%
FY2022Dec 31, 2022$96.48B-8.4%
FY2021Dec 31, 2021$105.36B+57.9%
FY2020Dec 31, 2020$66.73B+8.7%
FY2019Dec 31, 2019$61.38B+1.2%
FY2018Dec 31, 2018$60.65B-4.3%
FY2017Dec 31, 2017$63.35B+1.3%
FY2016Dec 31, 2016$62.53B+4.1%
FY2015Dec 31, 2015$60.06B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$115.83B+11.0%
Q4 FY2025Dec 31, 2025$114.07B+12.8%
Q2 FY2025Jun 30, 2025$112.42B+16.4%
Q4 FY2024Dec 31, 2024$104.04B+7.8%
Q2 FY2024Jun 30, 2024$104.34B+8.0%
Q4 FY2023Dec 31, 2023$101.12B-4.0%
Q2 FY2023Jun 30, 2023$96.54B+31.1%
Q4 FY2022Dec 31, 2022$96.48B+44.6%
Q2 FY2022Jun 30, 2022$96.58B+61.2%
Q4 FY2021Dec 31, 2021$105.36B+71.7%
Q2 FY2021Jun 30, 2021$73.64B+19.0%
Q4 FY2020Dec 31, 2020$66.73B+10.0%
Q2 FY2020Jun 30, 2020$59.93B-2.3%
Q4 FY2019Dec 31, 2019$61.38B-3.1%
Q2 FY2019Jun 30, 2019$61.89B-5.0%
Q4 FY2018Dec 31, 2018$60.65B-3.0%
Q2 FY2018Jun 30, 2018$61.34B+2.1%
Q4 FY2017Dec 31, 2017$63.35B–
Q2 FY2017Jun 30, 2017$65.12B–
Q4 FY2016Dec 31, 2016$62.53B–
Q4 FY2015Dec 31, 2015$60.06B–

More AstraZeneca figures

See a number that looks wrong?